Background/Aims: We aimed to evaluate the incidence and characteristics of adrenal crisis in Japanese children with 21-hydroxylase deficiency (21-OHD). Methods: We conducted a retrospective nationwide survey for the councilors of the Japanese Society for Pediatric Endocrinology (JSPE) regarding adrenal crisis in children under 7 years with 21-OHD, admitted to hospitals from 2011 through 2016. We defined adrenal crisis as the acute impairment of general health due to glucocorticoid deficiency with at least two of symptoms, signs, or biochemical abnormalities. Results: The councilors of the JSPE in 83 institutions responded to this survey (response rate, 60.1%). Data analyses of 378 patients with 1,101.4 person-years (PYs) revealed that 67 patients (17.7%) experienced at least 1 episode of hospital admission for adrenal crisis at the median age of 2 years. The incidence of adrenal crisis was calculated as 10.9 per 100 PYs (95% confidence interval [CI] 9.6–12.2). Infections were the most common precipitating factors, while no factor was observed in 12.5%. Hypoglycemia occurred concomitantly in 27.4%. One patient died from severe hypoglycemia, resulting in a mortality rate of 0.09 per 100 PYs (95% CI 0.0–0.2). Conclusion: Adrenal crisis is not rare and can be accompanied by disastrous hypoglycemia in children with 21-OHD.

1.
White
PC
,
Speiser
PW
.
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
.
Endocr Rev
.
2000
Jun
;
21
(
3
):
245
91
.
[PubMed]
0163-769X
2.
Miller
WL
,
Auchus
RJ
.
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders
.
Endocr Rev
.
2011
Feb
;
32
(
1
):
81
151
.
[PubMed]
0163-769X
3.
Puar
TH
,
Stikkelbroeck
NM
,
Smans
LC
,
Zelissen
PM
,
Hermus
AR
.
Adrenal crisis: still a deadly event in the 21st century
.
Am J Med
.
2016
Mar
;
129
(
3
):
339.e1
9
.
[PubMed]
0002-9343
4.
Allolio
B
.
Extensive expertise in endocrinology. Adrenal crisis
.
Eur J Endocrinol
.
2015
Mar
;
172
(
3
):
R115
24
.
[PubMed]
0804-4643
5.
Hahner
S
,
Spinnler
C
,
Fassnacht
M
,
Burger-Stritt
S
,
Lang
K
,
Milovanovic
D
, et al.
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study
.
J Clin Endocrinol Metab
.
2015
Feb
;
100
(
2
):
407
16
.
[PubMed]
0021-972X
6.
Odenwald
B
,
Nennstiel-Ratzel
U
,
Dörr
HG
,
Schmidt
H
,
Wildner
M
,
Bonfig
W
.
Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life
.
Eur J Endocrinol
.
2016
Feb
;
174
(
2
):
177
86
.
[PubMed]
1479-683X
7.
Hahner
S
,
Loeffler
M
,
Bleicken
B
,
Drechsler
C
,
Milovanovic
D
,
Fassnacht
M
, et al.
Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies
.
Eur J Endocrinol
.
2010
Mar
;
162
(
3
):
597
602
.
[PubMed]
0804-4643
8.
Reisch
N
,
Willige
M
,
Kohn
D
,
Schwarz
HP
,
Allolio
B
,
Reincke
M
, et al.
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency
.
Eur J Endocrinol
.
2012
Jul
;
167
(
1
):
35
42
.
[PubMed]
0804-4643
9.
Smans
LC
,
Van der Valk
ES
,
Hermus
AR
,
Zelissen
PM
.
Incidence of adrenal crisis in patients with adrenal insufficiency
.
Clin Endocrinol (Oxf)
.
2016
Jan
;
84
(
1
):
17
22
.
[PubMed]
0300-0664
10.
Morikawa
S
,
Nakamura
A
,
Fujikura
K
,
Fukushi
M
,
Hotsubo
T
,
Miyata
J
, et al.
Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo
.
Clin Pediatr Endocrinol
.
2014
Apr
;
23
(
2
):
35
43
.
[PubMed]
0918-5739
11.
Ishii
T
,
Anzo
M
,
Adachi
M
,
Onigata
K
,
Kusuda
S
,
Nagasaki
K
, et al.;
Mass Screening Committee
;
Japanese Society for Pediatric Endocrinology
;
Japanese Society for Mass Screening
.
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
.
Clin Pediatr Endocrinol
.
2015
Jul
;
24
(
3
):
77
105
.
[PubMed]
0918-5739
12.
Ono
Y
,
Ono
S
,
Yasunaga
H
,
Matsui
H
,
Fushimi
K
,
Tanaka
Y
.
Clinical features and practice patterns of treatment for adrenal crisis: a nationwide cross-sectional study in Japan
.
Eur J Endocrinol
.
2017
Mar
;
176
(
3
):
329
37
.
[PubMed]
0804-4643
13.
White
K
,
Arlt
W
.
Adrenal crisis in treated Addison’s disease: a predictable but under-managed event
.
Eur J Endocrinol
.
2010
Jan
;
162
(
1
):
115
20
.
[PubMed]
0804-4643
14.
Fischer
JE
,
Stallmach
T
,
Fanconi
S
.
Adrenal crisis presenting as hypoglycemic coma
.
Intensive Care Med
.
2000
Jan
;
26
(
1
):
105
8
.
[PubMed]
0342-4642
15.
Aso
K
,
Izawa
M
,
Higuchi
A
,
Kotoh
S
,
Hasegawa
Y
.
Stress doses of glucocorticoids cannot prevent progression of all adrenal crises
.
Clin Pediatr Endocrinol
.
2009
;
18
(
1
):
23
7
.
[PubMed]
0918-5739
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.